ThinkEquity acted as sole book running manager for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNAZ:
- TransCode Therapeutics, Inc. Announces Pricing of Public Offering
- TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
- Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
- Transcode Therapeutics regains compliance with Nasdaq listing requirements
- TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138